Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

16.42 0.33 +2.05%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
25.5×
Dividend yield
—
F-score
4/9
Altman Z
1.55
Beneish M
−2.91
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
691.00 1,247.40 5,864.30 6,040.30 6,393.60 7,386.10 7,512.40 6,967.20 6,783.60 6,552.20
Revenue Growth
(44.59%) 80.52% 370.12% 3.00% 5.85% 15.52% 1.71% (7.26%) (2.64%) (3.41%)
Cost of Revenue
372.00 814.60 4,044.50 4,119.60 4,313.10 4,883.40 4,909.60 4,603.40 4,504.30 4,412.80
Gross Profit
320.00 432.80 1,819.80 1,920.70 2,080.50 2,502.70 2,602.80 2,363.80 2,279.30 2,139.40
SG&A Expenses
283.00 449.70 1,405.30 1,368.90 1,373.70 1,530.50 1,472.60 1,506.60 1,641.10 1,595.50
Operating Income
— (210.40) 413.50 551.80 706.80 972.20 1,130.20 696.40 1,084.80 (246.20)
Interest Expense (Operating)
108.00 — — — — — — — — —
Non-operating Income/Expense
0.00 (249.80) (527.30) (511.20) (644.50) (219.20) (279.10) (285.90) (230.90) (195.10)
Non-operating Interest Expenses
— 200.90 523.80 440.00 307.60 217.40 265.80 284.80 218.80 169.80
EBT
(71.00) (460.20) (113.80) 40.60 62.30 753.00 851.10 410.50 853.90 (441.30)
Income Tax Provision
10.00 (314.90) (26.90) 2.80 (54.30) 180.40 164.60 89.40 142.40 88.90
Income after Tax
— (145.30) (86.90) 37.80 116.60 572.60 686.50 321.10 711.50 (530.20)
Dividends (Preferred)
— 0.00 269.50 372.90 64.60 64.60 24.20 — — —
Non-Controlling Interest
— (32.60) — — — — — — — —
Net Income Common
(42.00) (112.70) (356.40) (335.10) 52.00 508.00 662.30 321.10 711.50 (530.20)
EPS (Basic)
(0.08) (0.96) (0.65) (0.84) 0.09 0.86 1.02 0.48 1.05 (0.78)
EPS (Diluted)
(0.08) (0.96) (0.65) (0.84) 0.09 0.85 1.01 0.47 1.04 (0.78)
Shares (Basic, Weighted)
534.00 151.10 132.70 401.20 576.30 590.50 650.90 675.60 679.60 680.60
Shares (Diluted, Weighted)
534.00 151.10 132.70 401.20 583.40 599.60 679.40 678.40 681.90 680.60
Gross Margin
46.31% 34.70% 31.03% 31.80% 32.54% 33.88% 34.65% 33.93% 33.60% 32.65%
EBIT Margin
10.71% (16.87%) 7.05% 9.14% 11.05% 13.16% 15.04% 10.00% 15.99% (3.76%)
EBT margin
(10.27%) (36.89%) (1.94%) 0.67% 0.97% 10.19% 11.33% 5.89% 12.59% (6.74%)
Net Profit Margin
(6.08%) (9.03%) (6.08%) (5.55%) 0.81% 6.88% 8.82% 4.61% 10.49% (8.09%)
Free Cash Flow Margin
10.55% (15.45%) 2.78% 5.01% 13.58% 11.41% 9.45% 10.39% 10.20% 7.55%
EBITDA
98.00 (99.50) 859.50 984.20 1,125.60 1,367.70 1,551.40 1,111.70 1,501.50 172.50
EBIT
74.00 (210.40) 413.50 551.80 706.80 972.20 1,130.20 696.40 1,084.80 (246.20)
Income from Continuous Operations
— (145.30) (86.90) 37.80 116.60 572.60 686.50 321.10 711.50 (530.20)
Consolidated Net Income/Loss
(81.00) (145.30) (86.90) 37.80 116.60 572.60 686.50 321.10 711.50 (530.20)
EPS (Basic, from Continuous Ops)
— (0.96) (0.65) 0.09 0.20 0.97 1.05 0.48 1.05 (0.78)
EPS (Basic, Consolidated)
— (0.96) (0.65) 0.09 0.20 0.97 1.05 0.48 1.05 (0.78)
EPS (Diluted, from Cont. Ops)
— (0.96) (0.65) 0.09 0.20 0.96 1.01 0.47 1.04 (0.78)
Shares (Diluted, Average)
— — — 401.20 583.40 599.60 679.40 678.40 681.90 680.60
EPS (Diluted, Consolidated)
— (0.96) (0.65) 0.09 0.20 0.96 1.01 0.47 1.04 (0.78)
EBITDA Margin
14.18% (7.98%) 14.66% 16.29% 17.61% 18.52% 20.65% 15.96% 22.13% 2.63%
Operating Cash Flow Margin
10.55% (13.43%) 3.42% 5.86% 14.54% 12.91% 11.23% 12.49% 12.39% 9.52%

Fold the line items

In millions of $ except per-share values · columns are period end dates